Literature DB >> 23239283

Conditional deletion of histone deacetylase-4 in the central nervous system has no major effect on brain architecture or neuronal viability.

Valerie Price1, Lulu Wang, Santosh R D'Mello.   

Abstract

Evidence from different laboratories using cell culture and in vivo model systems indicates that histone deacetylase-4 (HDAC4) plays an essential role in maintaining neuronal survival. Indeed, HDAC4 null knockout mice, which die within 2 weeks of birth, display cerebellar degeneration, whereas RNAi-mediated knockdown of HDAC4 expression in the retina of normal mice leads to apoptosis of retinal neurons. As a step toward analyzing the role of HDAC4 in the regulation of neuronal survival in more detail, we generated two separate lines of conditional knockout mice by breeding HDAC4-flox mice with mice expressing Cre recombinase through a Thy1 or nestin promoter. Surprisingly, both Thy1-Cre/HDAC4(-/-) mice, in which HDAC4 is ablated in neurons of the cortex and hippocampus, as well as Nes-Cre/HDAC4(-/-) mice, in which HDAC4 is ablated in neural progenitor cells of the CNS, appear normal at birth, have normal body weight, are fertile, and perform normally in locomotor activity assays. Histological analysis of the brains of Nes-Cre/HDAC4(-/-) mice revealed no obvious abnormalities in cytoarchitecture. Immunohistological analysis of tyrosine hydroxylase and calbindin also showed no discernible defects. Terminal deoxynucleotidyl transferase dUTP nick end-labeling staining showed no difference in the level of neuronal death in the cortex and cerebellum of Nes-Cre/HDAC4(-/-) mice compared with controls. These results indicate that neurons are less dependent on HDAC4 expression for their survival than previously believed and suggest that neuronal death observed in HDAC4 null knockout mice and after RNAi injection may result from HDAC4 deficiency in nonneural cells.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23239283      PMCID: PMC3752780          DOI: 10.1002/jnr.23170

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  25 in total

1.  Novel hippocampal interneuronal subtypes identified using transgenic mice that express green fluorescent protein in GABAergic interneurons.

Authors:  A A Oliva; M Jiang; T Lam; K L Smith; J W Swann
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

2.  Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex.

Authors:  D Graus-Porta; S Blaess; M Senften; A Littlewood-Evans; C Damsky; Z Huang; P Orban; R Klein; J C Schittny; U Müller
Journal:  Neuron       Date:  2001-08-16       Impact factor: 17.173

3.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

4.  A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation.

Authors:  Jurre Hageman; Maria A Rujano; Maria A W H van Waarde; Vaishali Kakkar; Ron P Dirks; Natalia Govorukhina; Henderika M J Oosterveld-Hut; Nicolette H Lubsen; Harm H Kampinga
Journal:  Mol Cell       Date:  2010-02-12       Impact factor: 17.970

5.  Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis.

Authors:  Rick B Vega; Koichi Matsuda; Junyoung Oh; Ana C Barbosa; Xiangli Yang; Eric Meadows; John McAnally; Chris Pomajzl; John M Shelton; James A Richardson; Gerard Karsenty; Eric N Olson
Journal:  Cell       Date:  2004-11-12       Impact factor: 41.582

6.  Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.

Authors:  Ilse Dewachter; Delphine Reversé; Nathalie Caluwaerts; Laurence Ris; Cuno Kuipéri; Chris Van den Haute; Kurt Spittaels; Lieve Umans; Lutgarde Serneels; Els Thiry; Dieder Moechars; Mark Mercken; Emile Godaux; Fred Van Leuven
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

Review 7.  Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions.

Authors:  Sama F Sleiman; Manuela Basso; Lata Mahishi; Alan P Kozikowski; Mary E Donohoe; Brett Langley; Rajiv R Ratan
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206

8.  HDAC4 regulates neuronal survival in normal and diseased retinas.

Authors:  Bo Chen; Constance L Cepko
Journal:  Science       Date:  2009-01-09       Impact factor: 47.728

Review 9.  Histone deacetylases as targets for the treatment of human neurodegenerative diseases.

Authors:  Santosh R D'Mello
Journal:  Drug News Perspect       Date:  2009-11

10.  Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.

Authors:  Jonathan C Cruz; Huang-Chun Tseng; Joseph A Goldman; Heather Shih; Li-Huei Tsai
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

View more
  11 in total

Review 1.  Regulation of Central Nervous System Development by Class I Histone Deacetylases.

Authors:  Santosh R D'Mello
Journal:  Dev Neurosci       Date:  2020-01-24       Impact factor: 2.984

2.  Histone deacetylase 3 is necessary for proper brain development.

Authors:  Jordan Norwood; Jade M Franklin; Dharmendra Sharma; Santosh R D'Mello
Journal:  J Biol Chem       Date:  2014-10-22       Impact factor: 5.157

Review 3.  Histone deacetylase 4 (HDAC4): a new player in anorexia nervosa?

Authors:  Mari Sild; Linda Booij
Journal:  Mol Psychiatry       Date:  2019-02-11       Impact factor: 15.992

Review 4.  The role of histone modifications: from neurodevelopment to neurodiseases.

Authors:  Jisu Park; Kyubin Lee; Kyunghwan Kim; Sun-Ju Yi
Journal:  Signal Transduct Target Ther       Date:  2022-07-06

Review 5.  Lysine Acetylation and Deacetylation in Brain Development and Neuropathies.

Authors:  Alicia Tapias; Zhao-Qi Wang
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-02-02       Impact factor: 7.691

Review 6.  Impaired Regulation of Histone Methylation and Acetylation Underlies Specific Neurodevelopmental Disorders.

Authors:  Merrick S Fallah; Dora Szarics; Clara M Robson; James H Eubanks
Journal:  Front Genet       Date:  2021-01-08       Impact factor: 4.599

Review 7.  HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements.

Authors:  Michal Mielcarek; Daniel Zielonka; Alisia Carnemolla; Jerzy T Marcinkowski; Fabien Guidez
Journal:  Front Cell Neurosci       Date:  2015-02-24       Impact factor: 5.505

8.  Novel Histone Deacetylase Class IIa Selective Substrate Radiotracers for PET Imaging of Epigenetic Regulation in the Brain.

Authors:  Robin Bonomi; Uday Mukhopadhyay; Aleksandr Shavrin; Hsien-Hsien Yeh; Anjoy Majhi; Sajeewa W Dewage; Amer Najjar; Xin Lu; G Andrés Cisneros; William P Tong; Mian M Alauddin; Ren-Shuan Liu; Thomas J Mangner; Nashaat Turkman; Juri G Gelovani
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

9.  The histone deacetylase HDAC4 regulates long-term memory in Drosophila.

Authors:  Helen L Fitzsimons; Silvia Schwartz; Fiona M Given; Maxwell J Scott
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

10.  HDAC4 does not act as a protein deacetylase in the postnatal murine brain in vivo.

Authors:  Michal Mielcarek; Tamara Seredenina; Matthew P Stokes; Georgina F Osborne; Christian Landles; Linda Inuabasi; Sophie A Franklin; Jeffrey C Silva; Ruth Luthi-Carter; Vahri Beaumont; Gillian P Bates
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.